|
AU2019262918A1
|
|
Modulation of immune function by Bacillus coagulans
|
|
AU2019249392A1
|
|
Skin care compositions and their applications
|
|
EP3768237A1
|
|
Liver protectant compositions and therapeutic applications
|
|
AU2018397668A1
|
|
Compositions for the management of hyperglycemia and related conditions
|
|
EP3684900A1
|
|
Alcoholic beverage composition containingbacillus coagulans
|
|
RU2733372C1
|
|
Method of producing tripeptide containing oleanolic acid and its therapeutic applications
|
|
EP3614846A1
|
|
Garcinol compositions for therapeutic management of endoplasmic reticulum stress
|
|
AU2018290219A1
|
|
Process for the preparation of standardized composition of Arjunoglucoside from the bark of Terminalia arjuna
|
|
MX2019014841A
|
|
Anti-obesity potential of garcinol.
|
|
AU2018281141A1
|
|
Compositions for management of Helicobacter pylori infections
|
|
KR20200010514A
|
|
Skin Care Application of Extracellular Metabolites of Bacillus Coagulum
|
|
KR20200014848A
|
|
Anti-aging Potential of Extracellular Metabolites Isolated from Bacillus Coagulant MTCC 5856
|
|
AU2018282020A1
|
|
Hair care compositions containing extracellular metabolite preparation from bacillus coagulans
|
|
EP3635092A1
|
|
Compositions and methods for reducing flatulence
|
|
AU2018271887A1
|
|
Enzyme composition for management of metabolic health
|
|
AU2018279794A1
|
|
Hypolipidemic effects of Bacillus coagulans
|
|
KR20190131133A
|
|
Beverage Composition Containing Bacillus Coagulant MTCC 5856
|
|
KR20190084094A
|
|
Compositions Containing Oroxylin A and Extraction Method Thereof
|
|
EP3399987A1
|
|
Anti-cancer activity of (e)-1-(3',4'-dimethoxyphenyl) butadiene
|
|
AU2016428484A1
|
|
Enzyme composition for therapeutic management of muscle soreness
|
